Keros Therapeutics (NASDAQ:KROS) Major Shareholder Adar1 Capital Management, Llc Sells 5,389,264 Shares
MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS - Get Free Report) major shareholder Adar1 Capital Management, Llc sold 5,389,264 shares of the stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of $17.75, for a total value of $95,659,436.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
NASDAQ:KROS